Utilisation of primary care electronic patient records for identification and targeted invitation of individuals to a lung cancer screening programme
- PMID: 36179541
- PMCID: PMC10533413
- DOI: 10.1016/j.lungcan.2022.09.009
Utilisation of primary care electronic patient records for identification and targeted invitation of individuals to a lung cancer screening programme
Abstract
Lung cancer screening (LCS) eligibility is largely determined by tobacco consumption. Primary care smoking data could guide LCS invitation and eligibility assessment. We present observational data from the SUMMIT Study, where individual self-reported smoking status was concordant with primary care records in 75.3%. However, 10.3% demonstrated inconsistencies between historic and most recent smoking status documentation. Quantified tobacco consumption was frequently missing, precluding direct LCS eligibility assessment. Primary care recorded "ever-smoker" status, encompassing both recent and historic documentation, can be used to target LCS invitation. Identifying those with missing or erroneous "never-smoker" smoking status is crucial for equitable invitation to LCS.
Keywords: Lung cancer; Lung cancer screening.
Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- de Koning H.J., van der Aalst C.M., de Jong P.A., Scholten E.T., Nackaerts K., Heuvelmans M.A., Lammers J.-W., Weenink C., Yousaf-Khan U., Horeweg N., van ’t Westeinde S., Prokop M., Mali W.P., Mohamed Hoesein F.A.A., van Ooijen P.M.A., Aerts J.G.J.V., den Bakker M.A., Thunnissen E., Verschakelen J., Vliegenthart R., Walter J.E., ten Haaf K., Groen H.J.M., Oudkerk M. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N. Engl. J. Med. 2020;382(6):503–513. - PubMed
-
- Quaife S.L., Ruparel M., Dickson J.L., Beeken R.J., McEwen A., Baldwin D.R., Bhowmik A., Navani N., Sennett K., Duffy S.W., Wardle J., Waller J.o., Janes S.M. Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials. Am. J. Respir. Crit. Care Med. 2020;201(8):965–975. - PMC - PubMed
-
- Crosbie P.A., Balata H., Evison M., Atack M., Bayliss-Brideaux V., Colligan D., Duerden R., Eaglesfield J., Edwards T., Elton P., Foster J., Greaves M., Hayler G., Higgins C., Howells J., Irion K., Karunaratne D., Kelly J., King Z., Manson S., Mellor S., Miller D., Myerscough A., Newton T., O’Leary M., Pearson R., Pickford J., Sawyer R., Screaton N.J., Sharman A., Simmons M., Smith E., Taylor B., Taylor S., Walsham A., Watts A., Whittaker J., Yarnell L., Threlfall A., Barber P.V., Tonge J., Booton R. Implementing lung cancer screening: Baseline results from a community-based ‘Lung Health Check’ pilot in deprived areas of Manchester. Thorax. 2019;74(4):405–409. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical